Arcadia Biosciences Inc Share Price Nasdaq
Equities
US0390141051
Agricultural Chemicals
Sales 2024 * | 5.9M 465M | Sales 2025 * | 8M 630M | Capitalization | 4.16M 327M |
---|---|---|---|---|---|
Net income 2024 * | -9M -709M | Net income 2025 * | -8M -630M | EV / Sales 2024 * | 0.7 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.52 x |
P/E ratio 2024 * |
-0.5
x | P/E ratio 2025 * |
-0.66
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.51% |
Latest transcript on Arcadia Biosciences Inc
Managers | Title | Age | Since |
---|---|---|---|
Stanley Jacot
CEO | Chief Executive Officer | 54 | 01/02/22 |
Thomas Schaefer
DFI | Director of Finance/CFO | 48 | 30/06/20 |
Kevin Comcowich
CHM | Chairman | 55 | 31/10/16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Amy Yoder
BRD | Director/Board Member | 56 | 09/08/17 |
Gregory Waller
BRD | Director/Board Member | 74 | 12/06/17 |
Kevin Comcowich
CHM | Chairman | 55 | 31/10/16 |
1st Jan change | Capi. | |
---|---|---|
+17.80% | 39.34B | |
-.--% | 11.28B | |
+1.48% | 7.99B | |
+1.79% | 6.51B | |
-2.15% | 6.18B | |
+36.99% | 5.43B | |
-13.59% | 5.37B | |
-13.00% | 4.61B | |
+4.12% | 3.89B |